Annual report

Period2025-07-01 → 2026-06-30
Filed2026-09-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 144
MetricValuePeriodScopeSource row
Revenue¥3.9bn2025-07-01 → 2026-06-30Cons.Net sales
Revenue¥4.8bn2024-07-01 → 2025-06-30Cons.Net sales
Revenue¥5.2bn2023-07-01 → 2024-06-30vCons.Net sales (5-year summary)
Revenue¥8.1bn2022-07-01 → 2023-06-30vCons.Net sales (5-year summary)
Revenue¥9.3bn2021-07-01 → 2022-06-30vCons.Net sales (5-year summary)
Operating income¥276m2025-07-01 → 2026-06-30Cons.Operating income
Operating income−¥138m2024-07-01 → 2025-06-30Cons.Operating income
Ordinary income¥288m2025-07-01 → 2026-06-30Cons.Ordinary income
Ordinary income−¥129m2024-07-01 → 2025-06-30Cons.Ordinary income
Ordinary income−¥566m2023-07-01 → 2024-06-30vCons.Ordinary income loss (5-year summary)
Ordinary income¥727m2022-07-01 → 2023-06-30vCons.Ordinary income loss (5-year summary)
Ordinary income¥1.3bn2021-07-01 → 2022-06-30vCons.Ordinary income loss (5-year summary)
Profit before tax¥230m2025-07-01 → 2026-06-30Cons.Income before income taxes
Profit before tax−¥220m2024-07-01 → 2025-06-30Cons.Income before income taxes
Net income (owners)¥212m2025-07-01 → 2026-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥211m2024-07-01 → 2025-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥662m2023-07-01 → 2024-06-30vCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥452m2022-07-01 → 2023-06-30vCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥810m2021-07-01 → 2022-06-30vCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥212m2025-07-01 → 2026-06-30Cons.Profit loss
Net income−¥211m2024-07-01 → 2025-06-30Cons.Profit loss
Total assets¥6.9bnat 2026-06-30Cons.Assets
Total assets¥6.8bnat 2025-06-30Cons.Assets
Total assets¥6.9bnat 2024-06-30vCons.Total assets (5-year summary)
Total assets¥8.2bnat 2023-06-30vCons.Total assets (5-year summary)
Total assets¥8.5bnat 2022-06-30vCons.Total assets (5-year summary)
Total liabilities¥742mat 2026-06-30Cons.Liabilities
Total liabilities¥775mat 2025-06-30Cons.Liabilities
Net assets / equity¥6.1bnat 2026-06-30Cons.Net assets
Net assets / equity¥6.0bnat 2025-06-30Cons.Net assets
Net assets / equity¥6.2bnat 2024-06-30vCons.Net assets
Net assets / equity¥7.2bnat 2023-06-30vCons.Net assets (5-year summary)
Net assets / equity¥6.8bnat 2022-06-30vCons.Net assets (5-year summary)
Cash and deposits¥5.4bnat 2026-06-30Cons.Cash and deposits
Cash and deposits¥5.0bnat 2025-06-30Cons.Cash and deposits
Cash & equivalents¥5.4bnat 2026-06-30Cons.Cash and cash equivalents
Cash & equivalents¥5.0bnat 2025-06-30Cons.Cash and cash equivalents
Cash & equivalents¥4.8bnat 2024-06-30vCons.Cash and cash equivalents
Cash & equivalents¥5.9bnat 2023-06-30vCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥6.0bnat 2022-06-30vCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥415m2025-07-01 → 2026-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥558m2024-07-01 → 2025-06-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥881m2023-07-01 → 2024-06-30vCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥102m2022-07-01 → 2023-06-30vCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥2.1bn2021-07-01 → 2022-06-30vCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow¥119m2025-07-01 → 2026-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥389m2024-07-01 → 2025-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥14m2023-07-01 → 2024-06-30vCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥160m2022-07-01 → 2023-06-30vCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥245m2021-07-01 → 2022-06-30vCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥140m2025-07-01 → 2026-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥214,0002024-07-01 → 2025-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥261m2023-07-01 → 2024-06-30vCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥130m2022-07-01 → 2023-06-30vCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥130m2021-07-01 → 2022-06-30vCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥8.122025-07-01 → 2026-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-8.052024-07-01 → 2025-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-25.322023-07-01 → 2024-06-30vCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥17.272022-07-01 → 2023-06-30vCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.952021-07-01 → 2022-06-30vCons.Basic earnings loss per share (5-year summary)
Net assets per share¥233.56at 2026-06-30Cons.Net assets per share (5-year summary)
Net assets per share¥230.22at 2025-06-30Cons.Net assets per share (5-year summary)
Net assets per share¥238.28at 2024-06-30vCons.Net assets per share (5-year summary)
Net assets per share¥266.41at 2023-06-30vCons.Net assets per share (5-year summary)
Net assets per share¥254.14at 2022-06-30vCons.Net assets per share (5-year summary)
Equity ratio89.2%at 2026-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio88.4%at 2025-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio89.7%at 2024-06-30vCons.Equity to asset ratio (5-year summary)
Equity ratio84.6%at 2023-06-30vCons.Equity to asset ratio (5-year summary)
Equity ratio78.3%at 2022-06-30vCons.Equity to asset ratio (5-year summary)
ROE3.5%2025-07-01 → 2026-06-30Cons.Rate of return on equity (5-year summary)
ROE6.6%2022-07-01 → 2023-06-30vCons.Rate of return on equity (5-year summary)
ROE12.8%2021-07-01 → 2022-06-30vCons.Rate of return on equity (5-year summary)
Employees45at 2026-06-30Cons.Number of employees
Employees81at 2025-06-30Cons.Number of employees
Employees90at 2024-06-30vCons.Number of employees
Employees98at 2023-06-30vCons.Number of employees
Employees100at 2022-06-30vCons.Number of employees
Revenue¥838m2025-07-01 → 2026-06-30StandaloneNet sales
Revenue¥753m2024-07-01 → 2025-06-30StandaloneNet sales
Revenue¥304m2023-07-01 → 2024-06-30vStandaloneNet sales (5-year summary)
Revenue¥377m2022-07-01 → 2023-06-30vStandaloneNet sales (5-year summary)
Revenue¥439m2021-07-01 → 2022-06-30vStandaloneNet sales (5-year summary)
Operating income¥528m2025-07-01 → 2026-06-30StandaloneOperating income
Operating income¥409m2024-07-01 → 2025-06-30StandaloneOperating income
Ordinary income¥538m2025-07-01 → 2026-06-30StandaloneOrdinary income
Ordinary income¥420m2024-07-01 → 2025-06-30StandaloneOrdinary income
Ordinary income¥2m2023-07-01 → 2024-06-30vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥87m2022-07-01 → 2023-06-30vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥137m2021-07-01 → 2022-06-30vStandaloneOrdinary income loss (5-year summary)
Profit before tax¥262m2025-07-01 → 2026-06-30StandaloneIncome before income taxes
Profit before tax¥388m2024-07-01 → 2025-06-30StandaloneIncome before income taxes
Net income¥334m2025-07-01 → 2026-06-30StandaloneProfit loss
Net income¥448m2024-07-01 → 2025-06-30StandaloneProfit loss
Net income−¥10m2023-07-01 → 2024-06-30vStandaloneNet income loss (5-year summary)
Net income¥142m2022-07-01 → 2023-06-30vStandaloneNet income loss (5-year summary)
Net income¥195m2021-07-01 → 2022-06-30vStandaloneNet income loss (5-year summary)
Total assets¥4.9bnat 2026-06-30StandaloneAssets
Total assets¥4.7bnat 2025-06-30StandaloneAssets
Total assets¥4.2bnat 2024-06-30vStandaloneTotal assets (5-year summary)
Total assets¥4.3bnat 2023-06-30vStandaloneTotal assets (5-year summary)
Total assets¥4.5bnat 2022-06-30vStandaloneTotal assets (5-year summary)
Total liabilities¥62mat 2026-06-30StandaloneLiabilities
Total liabilities¥59mat 2025-06-30StandaloneLiabilities
Net assets / equity¥4.8bnat 2026-06-30StandaloneNet assets
Net assets / equity¥4.6bnat 2025-06-30StandaloneNet assets
Net assets / equity¥4.1bnat 2024-06-30vStandaloneNet assets
Net assets / equity¥4.3bnat 2023-06-30vStandaloneNet assets (5-year summary)
Net assets / equity¥4.3bnat 2022-06-30vStandaloneNet assets (5-year summary)
Cash and deposits¥2.8bnat 2026-06-30StandaloneCash and deposits
Cash and deposits¥2.4bnat 2025-06-30StandaloneCash and deposits
EPS (basic)¥12.762025-07-01 → 2026-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥17.112024-07-01 → 2025-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-0.42023-07-01 → 2024-06-30vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥5.442022-07-01 → 2023-06-30vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥7.472021-07-01 → 2022-06-30vStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥102025-07-01 → 2026-06-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥52024-07-01 → 2025-06-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥52022-07-01 → 2023-06-30vStandaloneDividend paid per share (5-year summary)
Dividend per share¥52021-07-01 → 2022-06-30vStandaloneDividend paid per share (5-year summary)
Net assets per share¥183.43at 2026-06-30StandaloneNet assets per share (5-year summary)
Net assets per share¥175.67at 2025-06-30StandaloneNet assets per share (5-year summary)
Net assets per share¥158.55at 2024-06-30vStandaloneNet assets per share (5-year summary)
Net assets per share¥163.95at 2023-06-30vStandaloneNet assets per share (5-year summary)
Net assets per share¥163.52at 2022-06-30vStandaloneNet assets per share (5-year summary)
Equity ratio98.7%at 2026-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio98.7%at 2025-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio99.3%at 2024-06-30vStandaloneEquity to asset ratio (5-year summary)
Equity ratio99.5%at 2023-06-30vStandaloneEquity to asset ratio (5-year summary)
Equity ratio95.6%at 2022-06-30vStandaloneEquity to asset ratio (5-year summary)
ROE7.1%2025-07-01 → 2026-06-30StandaloneRate of return on equity (5-year summary)
ROE10.2%2024-07-01 → 2025-06-30StandaloneRate of return on equity (5-year summary)
ROE3.3%2022-07-01 → 2023-06-30vStandaloneRate of return on equity (5-year summary)
ROE4.6%2021-07-01 → 2022-06-30vStandaloneRate of return on equity (5-year summary)
Shares issued26,158,200at 2026-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued26,158,200at 2025-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued26,158,200at 2024-06-30vStandaloneTotal number of issued shares (5-year summary)
Shares issued26,158,200at 2023-06-30vStandaloneTotal number of issued shares (5-year summary)
Shares issued26,158,200at 2022-06-30vStandaloneTotal number of issued shares (5-year summary)
Employees7at 2026-06-30StandaloneNumber of employees
Employees9at 2025-06-30StandaloneNumber of employees
Employees11at 2024-06-30vStandaloneNumber of employees
Employees7at 2023-06-30vStandaloneNumber of employees
Employees9at 2022-06-30vStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 94
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2025-07-01 → 2026-06-30¥355,000
Reconciling Itemsreconcilingdepreciation2025-07-01 → 2026-06-30¥419,000
Reconciling Itemsreconcilingrevenue2025-07-01 → 2026-06-30−¥52m
Reconciling Itemsreconcilingrevenue external2025-07-01 → 2026-06-30¥2m
Reconciling Itemsreconcilingrevenue intersegment2025-07-01 → 2026-06-30−¥53m
Reconciling Itemsreconcilingsegment assetsat 2026-06-30¥3.2bn
Reconciling Itemsreconcilingsegment profit2025-07-01 → 2026-06-30−¥309m
Clinical Evidence Servicereportable segmentcapex2025-07-01 → 2026-06-30¥316,000
Clinical Evidence Servicereportable segmentdepreciation2025-07-01 → 2026-06-30¥112,000
Clinical Evidence Servicereportable segmentemployeesat 2026-06-309 pure
Clinical Evidence Servicereportable segmentrevenue2025-07-01 → 2026-06-30¥215m
Clinical Evidence Servicereportable segmentrevenue external2025-07-01 → 2026-06-30¥215m
Clinical Evidence Servicereportable segmentsegment assetsat 2026-06-30¥324m
Clinical Evidence Servicereportable segmentsegment profit2025-07-01 → 2026-06-30¥15m
Functional Cosmetic Retailingreportable segmentemployeesat 2026-06-301 pure
Functional Cosmetic Retailingreportable segmentrevenue2025-07-01 → 2026-06-30¥907m
Functional Cosmetic Retailingreportable segmentrevenue external2025-07-01 → 2026-06-30¥883m
Functional Cosmetic Retailingreportable segmentrevenue intersegment2025-07-01 → 2026-06-30¥24m
Functional Cosmetic Retailingreportable segmentsegment assetsat 2026-06-30¥142m
Functional Cosmetic Retailingreportable segmentsegment profit2025-07-01 → 2026-06-30¥48m
Functional Food Retailingreportable segmentcapex2025-07-01 → 2026-06-30¥362,000
Functional Food Retailingreportable segmentdepreciation2025-07-01 → 2026-06-30¥8m
Functional Food Retailingreportable segmentemployeesat 2026-06-3013 pure
Functional Food Retailingreportable segmentrevenue2025-07-01 → 2026-06-30¥1.7bn
Functional Food Retailingreportable segmentrevenue external2025-07-01 → 2026-06-30¥1.7bn
Functional Food Retailingreportable segmentrevenue intersegment2025-07-01 → 2026-06-30¥15m
Functional Food Retailingreportable segmentsegment assetsat 2026-06-30¥2.4bn
Functional Food Retailingreportable segmentsegment profit2025-07-01 → 2026-06-30¥329m
Functional Material Developmentreportable segmentdepreciation2025-07-01 → 2026-06-30¥44,000
Functional Material Developmentreportable segmentemployeesat 2026-06-301 pure
Functional Material Developmentreportable segmentrevenue2025-07-01 → 2026-06-30¥311m
Functional Material Developmentreportable segmentrevenue external2025-07-01 → 2026-06-30¥297m
Functional Material Developmentreportable segmentrevenue intersegment2025-07-01 → 2026-06-30¥14m
Functional Material Developmentreportable segmentsegment assetsat 2026-06-30¥277m
Functional Material Developmentreportable segmentsegment profit2025-07-01 → 2026-06-30¥33m
Health Care Support Servicereportable segmentcapex2025-07-01 → 2026-06-30¥37m
Health Care Support Servicereportable segmentdepreciation2025-07-01 → 2026-06-30¥4m
Health Care Support Servicereportable segmentemployeesat 2026-06-3014 pure
Health Care Support Servicereportable segmentrevenue2025-07-01 → 2026-06-30¥787m
Health Care Support Servicereportable segmentrevenue external2025-07-01 → 2026-06-30¥787m
Health Care Support Servicereportable segmentsegment assetsat 2026-06-30¥451m
Health Care Support Servicereportable segmentsegment profit2025-07-01 → 2026-06-30¥160m
—segment totalcapex2025-07-01 → 2026-06-30¥37m
—segment totaldepreciation2025-07-01 → 2026-06-30¥13m
—segment totalrevenue2025-07-01 → 2026-06-30¥3.9bn
—segment totalrevenue external2025-07-01 → 2026-06-30¥3.9bn
—segment totalrevenue intersegment2025-07-01 → 2026-06-30¥53m
—segment totalsegment assetsat 2026-06-30¥3.6bn
—segment totalsegment profit2025-07-01 → 2026-06-30¥585m
Reconciling Itemsreconcilingcapex2024-07-01 → 2025-06-30¥548,000
Reconciling Itemsreconcilingdepreciation2024-07-01 → 2025-06-30¥557,000
Reconciling Itemsreconcilingrevenue2024-07-01 → 2025-06-30−¥26m
Reconciling Itemsreconcilingrevenue external2024-07-01 → 2025-06-30¥2m
Reconciling Itemsreconcilingrevenue intersegment2024-07-01 → 2025-06-30−¥28m
Reconciling Itemsreconcilingsegment assetsat 2025-06-30¥2.8bn
Reconciling Itemsreconcilingsegment profit2024-07-01 → 2025-06-30−¥343m
Clinical Evidence Servicereportable segmentcapex2024-07-01 → 2025-06-30¥4m
Clinical Evidence Servicereportable segmentdepreciation2024-07-01 → 2025-06-30¥6m
Clinical Evidence Servicereportable segmentrevenue2024-07-01 → 2025-06-30¥242m
Clinical Evidence Servicereportable segmentrevenue external2024-07-01 → 2025-06-30¥242m
Clinical Evidence Servicereportable segmentsegment assetsat 2025-06-30¥321m
Clinical Evidence Servicereportable segmentsegment profit2024-07-01 → 2025-06-30¥9m
Functional Cosmetic Retailingreportable segmentcapex2024-07-01 → 2025-06-30¥30m
Functional Cosmetic Retailingreportable segmentdepreciation2024-07-01 → 2025-06-30¥2m
Functional Cosmetic Retailingreportable segmentrevenue2024-07-01 → 2025-06-30¥1.5bn
Functional Cosmetic Retailingreportable segmentrevenue external2024-07-01 → 2025-06-30¥1.5bn
Functional Cosmetic Retailingreportable segmentsegment assetsat 2025-06-30¥745m
Functional Cosmetic Retailingreportable segmentsegment profit2024-07-01 → 2025-06-30¥27m
Functional Food Retailingreportable segmentcapex2024-07-01 → 2025-06-30¥357,000
Functional Food Retailingreportable segmentdepreciation2024-07-01 → 2025-06-30¥8m
Functional Food Retailingreportable segmentrevenue2024-07-01 → 2025-06-30¥2.1bn
Functional Food Retailingreportable segmentrevenue external2024-07-01 → 2025-06-30¥2.1bn
Functional Food Retailingreportable segmentrevenue intersegment2024-07-01 → 2025-06-30¥13m
Functional Food Retailingreportable segmentsegment assetsat 2025-06-30¥1.1bn
Functional Food Retailingreportable segmentsegment profit2024-07-01 → 2025-06-30¥91m
Functional Material Developmentreportable segmentdepreciation2024-07-01 → 2025-06-30¥297,000
Functional Material Developmentreportable segmentrevenue2024-07-01 → 2025-06-30¥298m
Functional Material Developmentreportable segmentrevenue external2024-07-01 → 2025-06-30¥283m
Functional Material Developmentreportable segmentrevenue intersegment2024-07-01 → 2025-06-30¥15m
Functional Material Developmentreportable segmentsegment assetsat 2025-06-30¥1.3bn
Functional Material Developmentreportable segmentsegment profit2024-07-01 → 2025-06-30−¥28m
Health Care Support Servicereportable segmentcapex2024-07-01 → 2025-06-30¥3m
Health Care Support Servicereportable segmentdepreciation2024-07-01 → 2025-06-30¥1m
Health Care Support Servicereportable segmentrevenue2024-07-01 → 2025-06-30¥688m
Health Care Support Servicereportable segmentrevenue external2024-07-01 → 2025-06-30¥688m
Health Care Support Servicereportable segmentsegment assetsat 2025-06-30¥528m
Health Care Support Servicereportable segmentsegment profit2024-07-01 → 2025-06-30¥107m
—segment totalcapex2024-07-01 → 2025-06-30¥37m
—segment totaldepreciation2024-07-01 → 2025-06-30¥18m
—segment totalrevenue2024-07-01 → 2025-06-30¥4.9bn
—segment totalrevenue external2024-07-01 → 2025-06-30¥4.8bn
—segment totalrevenue intersegment2024-07-01 → 2025-06-30¥28m
—segment totalsegment assetsat 2025-06-30¥4.0bn
—segment totalsegment profit2024-07-01 → 2025-06-30¥205m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,295
ItemContextValueUnit
Net assets per share (5-year summary)Prior1YearInstant_NonConsolidatedMember175.67
Net assets per share (5-year summary)CurrentYearInstant_NonConsolidatedMember183.43
Dividend paid per share (5-year summary)Prior4YearDuration_NonConsolidatedMember5.00
Dividend paid per share (5-year summary)Prior3YearDuration_NonConsolidatedMember5.00
Dividend paid per share (5-year summary)Prior2YearDuration_NonConsolidatedMember-
Dividend paid per share (5-year summary)Prior1YearDuration_NonConsolidatedMember5.00
Dividend paid per share (5-year summary)CurrentYearDuration_NonConsolidatedMember10.00
Interim dividend paid per share (5-year summary)Prior4YearDuration_NonConsolidatedMember-
Interim dividend paid per share (5-year summary)Prior3YearDuration_NonConsolidatedMember-
Interim dividend paid per share (5-year summary)Prior2YearDuration_NonConsolidatedMember-
Interim dividend paid per share (5-year summary)Prior1YearDuration_NonConsolidatedMember-
Interim dividend paid per share (5-year summary)CurrentYearDuration_NonConsolidatedMember-
Basic earnings loss per share (5-year summary)Prior4YearDuration_NonConsolidatedMember7.47
Basic earnings loss per share (5-year summary)Prior3YearDuration_NonConsolidatedMember5.44
Basic earnings loss per share (5-year summary)Prior2YearDuration_NonConsolidatedMember-0.40
Basic earnings loss per share (5-year summary)Prior1YearDuration_NonConsolidatedMember17.11
Basic earnings loss per share (5-year summary)CurrentYearDuration_NonConsolidatedMember12.76
Diluted earnings per share (5-year summary)Prior4YearDuration_NonConsolidatedMember-
Diluted earnings per share (5-year summary)Prior3YearDuration_NonConsolidatedMember-
Diluted earnings per share (5-year summary)Prior2YearDuration_NonConsolidatedMember-
Diluted earnings per share (5-year summary)Prior1YearDuration_NonConsolidatedMember-
Diluted earnings per share (5-year summary)CurrentYearDuration_NonConsolidatedMember-
Equity to asset ratio (5-year summary)Prior4YearInstant_NonConsolidatedMember0.956
Equity to asset ratio (5-year summary)Prior3YearInstant_NonConsolidatedMember0.995
Equity to asset ratio (5-year summary)Prior2YearInstant_NonConsolidatedMember0.993
Equity to asset ratio (5-year summary)Prior1YearInstant_NonConsolidatedMember0.987
Equity to asset ratio (5-year summary)CurrentYearInstant_NonConsolidatedMember0.987
Rate of return on equity (5-year summary)Prior4YearDuration_NonConsolidatedMember0.046
Rate of return on equity (5-year summary)Prior3YearDuration_NonConsolidatedMember0.033
Rate of return on equity (5-year summary)Prior2YearDuration_NonConsolidatedMember-
Rate of return on equity (5-year summary)Prior1YearDuration_NonConsolidatedMember0.102
Rate of return on equity (5-year summary)CurrentYearDuration_NonConsolidatedMember0.071
Price earnings ratio (5-year summary)Prior4YearDuration_NonConsolidatedMember44.98
Price earnings ratio (5-year summary)Prior3YearDuration_NonConsolidatedMember55.15
Price earnings ratio (5-year summary)Prior2YearDuration_NonConsolidatedMember-
Price earnings ratio (5-year summary)Prior1YearDuration_NonConsolidatedMember9.82
Price earnings ratio (5-year summary)CurrentYearDuration_NonConsolidatedMember16.69
Payout ratio (5-year summary)Prior4YearDuration_NonConsolidatedMember0.669
Payout ratio (5-year summary)Prior3YearDuration_NonConsolidatedMember0.919
Payout ratio (5-year summary)Prior2YearDuration_NonConsolidatedMember-
Payout ratio (5-year summary)Prior1YearDuration_NonConsolidatedMember0.292
Payout ratio (5-year summary)CurrentYearDuration_NonConsolidatedMember0.784
Number of employeesPrior4YearInstant_NonConsolidatedMember9
Number of employeesPrior3YearInstant_NonConsolidatedMember7
Number of employeesPrior2YearInstant_NonConsolidatedMember11
Number of employeesPrior1YearInstant_NonConsolidatedMember9
Number of employeesCurrentYearInstant_NonConsolidatedMember7
Average number of temporary workersPrior4YearInstant_NonConsolidatedMember1
Average number of temporary workersPrior3YearInstant_NonConsolidatedMember1
Average number of temporary workersPrior2YearInstant_NonConsolidatedMember0

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2025-06-30pass rounding
balance sheet identityconsolidated 2026-06-30pass
balance sheet identitynon_consolidated 2025-06-30pass
balance sheet identitynon_consolidated 2026-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-06-30pass
statement vs summary · net assetsconsolidated 2025-06-30pass
statement vs summary · net assetsconsolidated 2026-06-30pass
statement vs summary · net assetsnon_consolidated 2024-06-30pass
statement vs summary · net assetsnon_consolidated 2025-06-30pass
statement vs summary · net assetsnon_consolidated 2026-06-30pass
statement vs summary · net income attributable to parentconsolidated 2024-07-01/2025-06-30pass
statement vs summary · net income attributable to parentconsolidated 2025-07-01/2026-06-30pass
statement vs summary · operating cash flowconsolidated 2024-07-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2025-07-01/2026-06-30pass
statement vs summary · revenueconsolidated 2024-07-01/2025-06-30pass
statement vs summary · revenueconsolidated 2025-07-01/2026-06-30pass
statement vs summary · revenuenon_consolidated 2024-07-01/2025-06-30pass
statement vs summary · revenuenon_consolidated 2025-07-01/2026-06-30pass
statement vs summary · total assetsconsolidated 2025-06-30pass
statement vs summary · total assetsconsolidated 2026-06-30pass
statement vs summary · total assetsnon_consolidated 2025-06-30pass
statement vs summary · total assetsnon_consolidated 2026-06-30pass